Medicare Enrolled
Dr. Marco Chavez, MD
Family Medicine · Longview, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chavez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chavez? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chavez
Dr. Marco Chavez is a family medicine in Longview, TX, with 9 years in practice. Based on federal Medicare data, Dr. Chavez performed 8,001 Medicare services across 4,904 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chavez received a total of $8,202 from 45 pharmaceutical and/or device companies across 577 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chavez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice▲ Top 2% volume in TX$ $8,202 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,001
Medicare services
Top 2% in TX for family medicine
4,904
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~889 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 799 | $83 | $200 |
| Blood draw (venipuncture) | 578 | $8 | $20 |
| Basic metabolic blood panel | 546 | $8 | $59 |
| Assessment of emotional or behavioral problems | 520 | $3 | $20 |
| Lipid panel (cholesterol and triglycerides) | 453 | $13 | $66 |
| Liver function blood test panel | 446 | $8 | $51 |
| Complete blood count (CBC) with differential | 416 | $8 | $40 |
| Thyroid stimulating hormone (TSH) test | 413 | $16 | $70 |
| Urinalysis with microscopic exam | 392 | $3 | $22 |
| Hemoglobin A1c test (diabetes monitoring) | 304 | $9 | $60 |
| Vitamin B-12 level test | 288 | $15 | $77 |
| Annual wellness visit, follow-up | 185 | $125 | $130 |
| Prealbumin (protein) level | 178 | $14 | $50 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 140 | $78 | $150 |
| Complete blood count (CBC), automated | 119 | $6 | $35 |
| Urine culture, bacterial colony count | 107 | $8 | $35 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 98 | $30 | $70 |
| Hospital follow-up visit, moderate complexity | 88 | $58 | $120 |
| Automated urinalysis | 86 | $2 | $18 |
| Office visit, established patient, complex (40-54 min) | 85 | $135 | $270 |
| Magnesium level test | 76 | $7 | $24 |
| Phosphate level test | 72 | $5 | $25 |
| Flu vaccine administration | 70 | $29 | $31 |
| Office visit, established patient (20-29 min) | 65 | $60 | $135 |
| Chronic care management, first 20 min/month | 64 | $45 | $65 |
| Prostate cancer screening; prostate specific antigen test (psa) | 61 | $19 | $95 |
| Uric acid level test | 60 | $4 | $25 |
| Antibiotic sensitivity test | 60 | $8 | $40 |
| Flu vaccine, high-dose | 57 | $72 | $85 |
| Urine microalbumin test (kidney screening) | 53 | $6 | $70 |
| Creatinine test (kidney function) | 53 | $5 | $25 |
| 3D screening mammography (tomosynthesis) | 48 | $23 | $71 |
| Screening mammography | 47 | $88 | $300 |
| New patient office visit (45-59 min) | 47 | $96 | $310 |
| Annual depression screening | 47 | $18 | $20 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 46 | $282 | $305 |
| Urine culture, bacterial identification | 44 | $8 | $20 |
| Joint injection, major joint | 41 | $45 | $224 |
| Pneumonia vaccine administration | 41 | $29 | $30 |
| Iron level test | 39 | $6 | $35 |
| Drug injection, under skin or into muscle | 39 | $9 | $50 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 39 | $14 | $25 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 39 | $38 | $80 |
| Injection, methylprednisolone acetate, 40 mg | 39 | $5 | $15 |
| Ferritin level test (iron stores) | 36 | $13 | $72 |
| Electrocardiogram (EKG), 12-lead | 36 | $9 | $65 |
| Iron binding capacity test | 35 | $9 | $40 |
| Bone density scan (DEXA) | 31 | $27 | $80 |
| Transitional care management services for problem of high complexity | 25 | $200 | $410 |
| Removal of impacted ear wax | 23 | $33 | $179 |
| Bacterial culture, aerobic | 23 | $8 | $50 |
| Hospital discharge day management, 30 minutes or less | 22 | $62 | $115 |
| Natriuretic peptide (heart and blood vessel protein) level | 21 | $38 | $110 |
| Limited ultrasound scan behind abdominal cavity | 20 | $16 | $86 |
| Transitional care management services for problem of at least moderate complexity | 20 | $136 | $300 |
| New patient office visit, complex (60-74 min) | 19 | $151 | $400 |
| Injection, methylprednisolone acetate, 80 mg | 19 | $8 | $20 |
| PSA test (prostate cancer screening) | 18 | $18 | $95 |
| Removal of impacted ear wax by washing | 17 | $13 | $59 |
| Initial hospital admission, moderate complexity | 17 | $100 | $220 |
| Chest X-ray, 2 views | 15 | $18 | $64 |
| Parathyroid hormone level test | 15 | $40 | $280 |
| Prothrombin time test (blood clotting) | 15 | $4 | $23 |
| Free thyroxine (T4) test | 14 | $9 | $41 |
| Comprehensive metabolic blood panel | 13 | $10 | $105 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 13 | $17 | $30 |
| Low dose ct scan of chest for lung cancer screening | 12 | $87 | $271 |
| Administration of vaccine | 12 | $12 | $50 |
| X-ray of lower and sacral spine, minimum of 4 views | 11 | $22 | $107 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $160 | $252 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,202
Total received (2018-2024)
Avg $1,367/year across 6 years
Top 7% in TX for family medicine
45
Companies
577
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,202 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,751
2023$2,294
2022$1,958
2021$1,643
2020$481
2018$76
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,034
PFIZER INC.
$690
GlaxoSmithKline, LLC.
$628
Lilly USA, LLC
$556
Boehringer Ingelheim Pharmaceuticals, Inc.
$553
Amgen Inc.
$552
AbbVie Inc.
$514
AstraZeneca Pharmaceuticals LP
$436
Novartis Pharmaceuticals Corporation
$362
ABBVIE INC.
$343
Merck Sharp & Dohme LLC
$325
Teva Pharmaceuticals USA, Inc.
$250
Astellas Pharma US Inc
$204
Otsuka America Pharmaceutical, Inc.
$176
Amarin Pharma Inc.
$173
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$161
Janssen Pharmaceuticals, Inc
$120
Bayer HealthCare Pharmaceuticals Inc.
$118
Exact Sciences Corporation
$110
SHIELD THERAPEUTICS INC
$105
Daiichi Sankyo Inc.
$82
Biohaven Pharmaceutical Holding Company Ltd.
$65
Lundbeck LLC
$60
Eisai Inc.
$57
ITI, Inc.
$45
IDORSIA PHARMACEUTICALS US INC
$44
Phathom Pharmaceuticals, Inc.
$40
Merck Sharp & Dohme Corporation
$38
Dynavax Technologies Corporation
$37
Tris Pharma Inc
$35
Radius Health, Inc.
$35
Bioventus LLC
$33
Takeda Pharmaceuticals U.S.A., Inc.
$30
Antares Pharma, Inc.
$22
Nevro Corp.
$20
Allergan, Inc.
$19
Almatica Pharma LLC
$18
Sumitomo Pharma America, Inc.
$18
INOGEN, INC.
$17
EISAI INC.
$15
SANOFI-AVENTIS U.S. LLC
$14
Boston Scientific Corporation
$14
Paratek Pharmaceuticals, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Biohaven Pharmaceuticals, Inc.
$12
Top 3 companies account for 28.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · AUSTEDO · Aimovig · AirDuo Digihaler · Austedo XR · BASAGLAR · BELSOMRA · BREZTRI · CAPLYTA · Cologuard Collection Kit · Dayvigo · Durolane · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · GARDASIL · GELSYN-3 · GEMTESA · GRALISE · Heplisav-B · INJECTAFER · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · Livalo · MOUNJARO · Myrbetriq · NOCDURNA · NURTEC ODT · NUZYRA · OFEV · Omnia · Otezla · Ozempic · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · SYNJARDY · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYEPTI · Vascepa · Veozah · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in TX.
Equivalent to $103 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
81
Per 100K population
64.9
County median income
$64,809
Nearest hospital
LONGVIEW REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chavez is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 7%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chavez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chavez performed 799 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chavez receive payments from pharmaceutical companies?
Yes. Dr. Chavez received a total of $8,202 from 45 companies across 577 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chavez's costs compare to other family medicines in Longview?
Dr. Chavez's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chavez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Longview
Browse family medicines in Longview ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology